NCT07071116 · St. Jude Children's Research Hospital
Seminar in Unwavering Empowering Presence Optimized for Rehabilitation Teams
What this study is about
The goal of this study to test the feasibility, acceptability, and potential impact of a serious illness communication skills training (CST) tailored to rehabilitation professionals to improve their comfort and confidence in navigating difficult conversations with patients and families.
View original scientific description
The goal of this study to test the feasibility, acceptability, and potential impact of a serious illness communication skills training (CST) tailored to rehabilitation professionals to improve their comfort and confidence in navigating difficult conversations with patients and families. Primary Objectives: Aim 1: To assess feasibility and acceptability of a multidisciplinary co-designed interactive CST program for rehabilitation professionals who care for children with serious illness and their families. Aim 2: To characterize the potential impact of this CST intervention on pediatric rehabilitation professionals. Secondary Objective: Aim 3: To examine the perspectives of bereaved parent educators on participation in the implementation of communication training for rehabilitation professionals.
Interventions
OTHER
Communication skills training
See Detailed Description
OTHER
Communication skills training-Facilitator
See Detailed Description
Primary outcome measures
Proportion of participants who achieve a mean score ≥3 on the Feasibility of Intervention Measure (FIM) scale
Time frame: Approximately 3 months post intervention
Investigators will compute the mean Feasibility of Intervention Measure (FIM) score for each participant using the Feasibility of Intervention Measure (FIM) and report the proportion of participants who achieve a mean score ≥3. The Feasibility of Intervention Measure (FIM) is used to assess how feasible it is to implement a specific intervention. The FIM measure includes four itemized responses that are scored from one to five (1=Completely disagree, 2=Disagree, 3=Neither agree nor disagree, 4=Agree, 5=Completely agree) such that one represents the lowest possible mean score and five the highest possible mean score. It is scored by averaging the responses to each of the four questions. Higher scores indicate greater perceived feasibility of the intervention.
Proportion of participants who achieve a mean score ≥3 on Acceptability of Intervention Measure (AIM) scale
Time frame: Approximately 3 months post intervention
Investigators will compute the mean Acceptability of Intervention Measure (AIM) score for each participant and report the proportion of participants who achieve a mean score ≥3. The Acceptability of Intervention Measure (AIM) is a four-item scale used to assess the acceptability of an intervention. It is scored by calculating the mean of the responses to its four items, each measured on a 5-point Likert scale(1=Completely disagree, 2=Disagree, 3=Neither agree nor disagree, 4=Agree, 5=Completely agree). This results in a final score ranging from 1 to 5, with higher scores indicating greater acceptability.
Proportion of participants who achieve a mean score ≥3 on the Intervention Appropriateness Measure (IAM) scale
Time frame: Approximately 3 months post intervention
Investigators will compute the mean Intervention Appropriateness Measure (IAM) score for each participant and report the proportion of participants who achieve a mean score ≥3. The Intervention Appropriateness Measure (IAM) is a four-item scale used to assess the appropriateness of interventions by capturing individual perspectives on the alignment of the intervention with professional values and perceived efficacy in meeting patient needs. Each item is rated on a 5-point Likert scale (1=Completely disagree, 2=Disagree, 3=Neither agree nor disagree, 4=Agree, 5=Completely agree). The score is calculated by averaging the responses to all items. A higher score on the IAM indicates a stronger perception that the intervention is appropriate for the given situation and context.
Potential impact of this CST intervention on pediatric rehabilitation professionals
Time frame: Prior to the start of the intervention (day 1) and at the end of study, approximately 3 months
Investigators will calculate the proportions of participants who select "Agree" or "Completely agree" in both the pre- and post-intervention surveys and conduct statistical tests, such as Fisher's exact test or the Chi-square test, to determine whether the change in these proportions over time is statistically significant.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Intervention Participants
- Licensed rehabilitation professionals (e.g., physical therapists, occupational therapists, speech-language pathologists) employed at St. Jude Children's Research Hospital actively involved in the care of pediatric oncology patients.
- Willingness to participate in the communication skills training (CST) intervention and associated study activities. Inclusion Criteria: Intervention Facilitators
- St. Jude Bereaved Parent Educators who have participated as an educator in at least one other institutional educational event
- Willingness to facilitate the communication skills training (CST) intervention and complete associated study activities.
Exclusion criteria
- Intervention Participants
- Non-rehabilitation professionals
- Individuals unable to attend the CST intervention session. Exclusion Criteria: Intervention Facilitators
- Individuals unable to attend the CST intervention session.
Where
- Memphis, Tennessee
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jul 13, 2026 · Source of record for eligibility and locations